Cargando…

Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice

The genus Henipavirus (HNVs) includes two fatal viruses, namely Nipah virus (NiV) and Hendra virus (HeV). Since 1994, NiV and HeV have been endemic to the Asia–Pacific region and responsible for more than 600 cases of infections. Two emerging HNVs, Ghana virus (GhV) and Mojiang virus (MojV), are spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yaohui, Li, Ruihua, Wang, Meirong, Liu, Yujiao, Yin, Ying, Zai, Xiaodong, Song, Xiaohong, Chen, Yi, Xu, Junjie, Chen, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232446/ https://www.ncbi.nlm.nih.gov/pubmed/32340278 http://dx.doi.org/10.3390/v12040480

Ejemplares similares

Nipah virus attachment glycoprotein ectodomain delivered by type 5 adenovirus vector elicits broad immune response against NiV and HeV
por: Huang, Xiaoyan, et al.
Publicado: (2023)

Designer antigens for elicitation of broadly neutralizing antibodies against HIV
por: Kok, Tuckweng, et al.
Publicado: (2014)

Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows
por: Sok, Devin, et al.
Publicado: (2017)

A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses
por: Amaya, Moushimi, et al.
Publicado: (2023)

RBD(206)-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern
por: Zhou, Chuge, et al.
Publicado: (2021)

Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo
por: Borisevich, Viktoriya, et al.
Publicado: (2016)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
por: Ahmed, Yousuf, et al.
Publicado: (2017)

Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
por: Parsons, Matthew S., et al.
Publicado: (2018)

Henipaviruses
por: Broder, Christopher C., et al.
Publicado: (2016)

Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
por: Huang, Deli, et al.
Publicado: (2020)

Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
por: McCoy, Laura E., et al.
Publicado: (2012)

Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV
por: Conti, Simone, et al.
Publicado: (2022)

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2021)

Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies
por: Chervyakova, Olga V., et al.
Publicado: (2016)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies
por: Sheward, Daniel J., et al.
Publicado: (2022)

Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells
por: Huang, Deli, et al.
Publicado: (2020)

Henipavirus and Tioman Virus Antibodies in Pteropodid Bats, Madagascar
por: Iehlé, Catherine, et al.
Publicado: (2007)

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
por: Demminger, Daniel E, et al.
Publicado: (2020)

Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
por: Luo, Mengxiao, et al.
Publicado: (2023)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
por: Khalil, Ahmed M., et al.
Publicado: (2023)

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
por: Richardson, Simone I., et al.
Publicado: (2019)

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
por: Richardson, Simone I., et al.
Publicado: (2021)

Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants
por: Liu, Yubin, et al.
Publicado: (2023)

Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection
por: Zang, Jinkai, et al.
Publicado: (2021)

The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires
por: Prabakaran, Ponraj, et al.
Publicado: (2014)

Pathogenicity and virulence of henipaviruses
por: Kaza, Benjamin, et al.
Publicado: (2023)

Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology
por: Zai, Xiaodong, et al.
Publicado: (2021)

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2014)

Recombinant Encephalomyocarditis Viruses Elicit Neutralizing Antibodies against PRRSV and CSFV in Mice
por: Zhu, Shu, et al.
Publicado: (2015)

Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
por: Liu, Xianglei, et al.
Publicado: (2020)

Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species
por: Laing, Eric D., et al.
Publicado: (2018)

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2022)

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
por: Seow, Jeffrey, et al.
Publicado: (2023)

Elicitation of potent neutralizing antibodies in obese mice by ISA 51-adjuvanted SARS-CoV-2 spike RBD-Fc vaccine
por: Li, Chia-Jung, et al.
Publicado: (2023)

Targeted Strategies for Henipavirus Therapeutics
por: Bossart, Katharine N, et al.
Publicado: (2007)

Henipavirus RNA in African Bats
por: Drexler, Jan Felix, et al.
Publicado: (2009)

Animal Models for Henipavirus Research
por: Pigeaud, Declan D., et al.
Publicado: (2023)

Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner
por: Mullarkey, Caitlin E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o7bh8rl6rog29udta74vjqc0ps